Mr. Jourde began his career with The Estée Lauder Companies in Germany in 2004 as the Brand Manager for Estée Lauder and Aramis Designer Fragrances, later adding Tom Ford to his responsibilities. Prior to joining the Estée Lauder Companies, Mr. Jourde worked in various senior positions at L’Oréal International on brands such as La Roche-Posay, Biotherm and Vichy. Mr. Jourde has worked in various international markets including Canada where he spent four years.
Introduced in 1968, Clinique was the first ever dermatologist-created, prestige cosmetic brand. Clinique’s mission has always been to provide the highest quality and most effective line of products to enhance every skin type and tone. The brand’s customized approach and quality products – all meticulously tested and carefully formulated with the latest science – have made Clinique one of the leading skin care authorities in the world. All makeup and skin care products are Allergy Tested and 100% Fragrance Free. Clinique offers products for men and women of all ages and ethnicities. Clinique is sold in more than 150 countries and territories and on www.clinique.com.
About the The Estée Lauder Companies Inc. (NYSE:EL)The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in over 150 countries and territories under the following brand names: Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, M•A•C, Bobbi Brown, Tommy Hilfiger, Kiton, La Mer, Donna Karan, Aveda, Jo Malone, Bumble and bumble , Darphin, Michael Kors, American Beauty, Flirt!, GoodSkin Labs, Grassroots Research Labs, Tom Ford, Coach, Ojon, Smashbox, Ermenegildo Zegna, Aerin Beauty, Osiao and Marni.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV